Stay updated on Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The footer revision changed from v3.7.1 to v3.7.2; the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T14:43:54.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The site's footer revision identifier changed from v3.7.0 to v3.7.1. The study record view still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T15:17:55.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    The study page now renders a 403 Forbidden error page, replacing the expected study content with an access-denied screen. This indicates an access restriction rather than an update to the study details.
    Difference
    19%
    Check dated 2026-09-20T19:16:24.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The page revision label was updated from v3.6.5 to v3.6.6. This update indicates a new page version for maintenance and backend fixes without altering the displayed study content.
    Difference
    0.0%
    Check dated 2026-08-30T22:22:25.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    The revision tag on the page updated from v3.6.4 to v3.6.5. This represents a minor administrative update to the page rather than changes to study content.
    Difference
    0.0%
    Check dated 2026-08-09T11:00:01.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, indicating a minor update to the page metadata. It does not alter study content or participant-facing information.
    Difference
    0.0%
    Check dated 2026-07-25T17:55:18.000Z thumbnail image

Stay in the know with updates to Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.